Pegolide and heart valve problems
admin October 28th, 2004
Sire BioChem Inc in association with Health Canada have issued a Dear Healthcare Professional letter warning of a greater risk of cardiac valvulopathy in patients being treated with pergolide for Parkinson’s disease.
Dear Healthcare Professional letter
Notice for Patients
- Health Canada
- Comments Off